AGP Picks
View all

Africa News Observer
Provided by AGP

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on June 4, 2026

AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness
Jun. 4, 2026

AIM ImmunoTech Releases Virtual Investor ‘What This Means’ Video Segment Discussing Ampligen’s Potential in Ebola Virus Disease Preparedness

Indeterminate GlobeNewswire
RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd
Jun. 4, 2026

RenovoRx CEO, Shaun Bagai, to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23rd

Indeterminate GlobeNewswire
Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome
Jun. 4, 2026

Quoin Pharmaceuticals Announces Japan's MHLW Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Indeterminate GlobeNewswire
Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting
Jun. 4, 2026

Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting

Indeterminate GlobeNewswire
GoldHaven Advances Copeçal Toward Q3 Drilling; Identifies Priority Eastern Targets
Jun. 4, 2026

GoldHaven Advances Copeçal Toward Q3 Drilling; Identifies Priority Eastern Targets

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies
Jun. 4, 2026

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Eyeing Nanotech-Driven Delivery Systems, Pharmacokinetic Optimization to Advance Existing Oncology Therapies

Indeterminate GlobeNewswire
BitMEX Integrates with Banxa to Expand On and Off-Ramp Offerings
Jun. 4, 2026

BitMEX Integrates with Banxa to Expand On and Off-Ramp Offerings

Indeterminate GlobeNewswire
Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution
Jun. 4, 2026

Amneal Announces U.S. FDA Approval of Romidepsin Injection Solution

Indeterminate GlobeNewswire
Aya Gold & Silver Releases its 2025 Sustainability Report
Jun. 4, 2026

Aya Gold & Silver Releases its 2025 Sustainability Report

Indeterminate GlobeNewswire
Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease
Jun. 4, 2026

Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

Indeterminate GlobeNewswire
Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution
Jun. 4, 2026

Onco360® Has Been Selected as a National Specialty Pharmacy Provider for JYLAMVO® (methotrexate) Oral Solution

Indeterminate GlobeNewswire
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society
Jun. 4, 2026

AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society

Indeterminate GlobeNewswire
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026
Jun. 4, 2026

Ocular Therapeutix™ to Participate in Clinical Trials at the Summit 2026

Indeterminate GlobeNewswire
Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial
Jun. 4, 2026

Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral’s Tigris Trial

Indeterminate GlobeNewswire
Der Zoomex-Prognosemarkt startet offiziell: Mit Krypto an globalen Trend-Events teilnehmen
Jun. 4, 2026

Der Zoomex-Prognosemarkt startet offiziell: Mit Krypto an globalen Trend-Events teilnehmen

Indeterminate GlobeNewswire
Zoomex Prediction Market Officially Launches: Participate in Global Trending Events with Crypto
Jun. 4, 2026

Zoomex Prediction Market Officially Launches: Participate in Global Trending Events with Crypto

Indeterminate GlobeNewswire
El Mercado de Predicciones de Zoomex se lanza oficialmente: participa en eventos tendencia globales con cripto
Jun. 4, 2026

El Mercado de Predicciones de Zoomex se lanza oficialmente: participa en eventos tendencia globales con cripto

Indeterminate GlobeNewswire
Le Marché de Prédictions Zoomex est officiellement lancé : participez aux événements tendance mondiaux avec la crypto
Jun. 4, 2026

Le Marché de Prédictions Zoomex est officiellement lancé : participez aux événements tendance mondiaux avec la crypto

Indeterminate GlobeNewswire
MEXC Integrates with TradingView to Deliver Seamless Crypto Derivatives Trading Experience
Jun. 4, 2026

MEXC Integrates with TradingView to Deliver Seamless Crypto Derivatives Trading Experience

Indeterminate GlobeNewswire
Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS
Jun. 4, 2026

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Observer

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.